Literature DB >> 23852724

Amniotic fluid stem cells prevent development of ascites in a neonatal rat model of necrotizing enterocolitis.

Augusto Zani1, Mara Cananzi1, Giuseppe Lauriti1, Francesco Fascetti-Leon1, Jack Wells2, Bernard Siow2, Mark F Lythgoe2, Agostino Pierro1, Simon Eaton1, Paolo De Coppi1.   

Abstract

AIM: It has been demonstrated that in a neonatal rat model of necrotizing enterocolitis (NEC), amniotic fluid stem (AFS) cells decrease intestinal damage and improve survival via modulation of stromal cells expressing cyclooxygenase 2 in the lamina propria. Herein, we aimed to evaluate the effect of AFS cells on body weight and fluid retention in this NEC model. Methods AFS cells were obtained from green fluorescent protein (GFP) + pregnant rats at E16 and expanded in culture. A total of 185 neonatal rats had NEC induced by gavage feeding of hypertonic formula + hypoxia + oral lipopolysaccharide (4 mg/kg/d) and were randomized to intraperitoneal phosphate buffered saline (PBS, n = 93) or AFS cells (n = 92). A total of 36 breastfed (BF) rats were used as controls. All rats were being killed at 96 hours of life. Groups were compared for body weight and presence of free intraperitoneal fluid using nonparametric and contingency tests. Data are expressed as mean ± standard deviation.
RESULTS: There were no differences in birth weight among the groups (PBS = 5.6 ± 0. 3 g; AFS cells = 5.6 ± 0. 3 g; BF = 5.6 ± 0. 3 g; p = 1). The body weight at randomization was not different between PBS (5.61 ± 0. 5 g) and AFS cells (5.60 ± 0. 5; p = 1) rats. After the rats were killed, BF rats were significantly heavier (12.5 ± 0.1 g) than PBS (5.12 ± 0.4 g) and AFS cell rats (4.95 ± 0.3; p < 0.0001). From randomization to being killed, PBS rats had 9% of weight loss in comparison with 12% in AFS cell rats (p = 0.08). After the rats were killed, 42 (45%) PBS rats developed ascites with evident abdominal distension in comparison with 19 (21%) AFS cells (p = 0.0005). None of BF animals had ascites.
CONCLUSION: Gavage feeding and undernutrition severely affect growth in this model of NEC. Administration of AFS cells result in lower incidence of ascites than in PBS rats. This could explain the differences in body weight between the two groups of rats that were killed. Furthermore, studies on liver function and fluid composition are needed to investigate our speculation. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852724     DOI: 10.1055/s-0033-1350059

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  14 in total

1.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.

Authors:  Argyro Kagia; Maria Tzetis; Emmanuel Kanavakis; Despina Perrea; Irene Sfougataki; Anny Mertzanian; Ioanna Varela; Aikaterini Dimopoulou; Angeliki Karagiannidou; Evgenios Goussetis
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 2.  Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?

Authors:  Ana I Flores; Gonzalo J Gómez-Gómez; Ángeles Masedo-González; M Pilar Martínez-Montiel
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Necrotizing enterocolitis: Pathophysiology from a historical context.

Authors:  David Hackam; Michael Caplan
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

4.  Evaluating the efficacy of different types of stem cells in preserving gut barrier function in necrotizing enterocolitis.

Authors:  Christopher J McCulloh; Jacob K Olson; Yijie Wang; Jennifer Vu; Sarah Gartner; Gail E Besner
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

5.  Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells.

Authors:  Christopher J McCulloh; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2017-03-18       Impact factor: 2.545

Review 6.  Recent Advances in Necrotizing Enterocolitis Research: Strategies for Implementation in Clinical Practice.

Authors:  Mohan Pammi; Isabelle G De Plaen; Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2020-03-04       Impact factor: 3.430

7.  Inhibiting hydrogen sulfide production in umbilical stem cells reduces their protective effects during experimental necrotizing enterocolitis.

Authors:  Natalie A Drucker; Jan P Te Winkel; W Christopher Shelley; Kenneth R Olson; Troy A Markel
Journal:  J Pediatr Surg       Date:  2019-03-01       Impact factor: 2.545

8.  The administration of amnion-derived multipotent cell secretome ST266 protects against necrotizing enterocolitis in mice and piglets.

Authors:  Chhinder P Sodhi; Raheel Ahmad; Hongpeng Jia; William B Fulton; Carla Lopez; Andres J Gonzalez Salazar; Asuka Ishiyama; Maame Sampah; Steve Steinway; Sanxia Wang; Thomas Prindle; Menghan Wang; David L Steed; Howard Wessel; Ziv Kirshner; Larry R Brown; Peng Lu; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-07-12       Impact factor: 4.871

9.  Amniotic fluid stem cell administration can prevent epithelial injury from necrotizing enterocolitis.

Authors:  Bo Li; Carol Lee; Marissa Cadete; Joshua S O'Connell; Mashriq Alganabi; Dorothy Lee; Niloofar Ganji; Hiromu Miyake; Steven R Botts; Kathene C Johnson-Henry; Pekka Maattanen; Philip M Sherman; Agostino Pierro
Journal:  Pediatr Res       Date:  2021-09-24       Impact factor: 3.756

10.  Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.

Authors:  Victoria G Weis; Anna C Deal; Gehad Mekkey; Cara Clouse; Michaela Gaffley; Emily Whitaker; Cole B Peeler; Jared A Weis; Marshall Z Schwartz; Anthony Atala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-02-10       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.